Pharmaceutical industry in Germany : R&D

TRADELABOR has more than 20 years of experience in the control and treatment of air, working with an experienced and qualified technical staff and with the most advanced technology in this area, which together guarantee the quality of the services provided.

 

 

No industry sector invested more in research and development (R&D) than the pharmaceutical industry. According to the latest report of the Expert Commission on Research and Innovation (EFI), the pharmaceutical industry reinvested 14 % of its turnover from its own products in internal R&D projects.

As in previous years, it is ahead of the automotive, aerospace, mechanical engineering and chemical industries, making it the most research-intensive sector in Germany.

This trend is not limited to Germany alone. The “EU Industrial R&D Investment Scoreboard 2018” of the EU also places the pharmaceutical industry at the top of the ranking of the most innovative industrial sectors with an R&D rate of 15 %.

The high R&D expenditures of the pharmaceutical industry are due to the partly very complex, long, highly sensitive and strongly regulated drug development. According to calculations by various scientists – such as Donald W. Light, Rebecca Warburton, Matthew Herper or Joseph DiMasi –
costs of more than one billion euros can be incurred depending on the drug.

 

Continue at: https://www.bpi.de/fileadmin/user_upload/Downloads/Publikationen/Pharma-Daten/Pharma-Daten_2019_EN.pdf

 

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

www.manostaxx.com

 

Manostaxx
Manostaxx – Industrial Management Consulting

Leave a Reply

Your email address will not be published. Required fields are marked *